Safety: 62% of participants reported treatment-emergent adverse events
Typical milestones during the first six months of a physician-supervised GLP-1 program
I talk about my business, The Pharmacists Voice, LLC, Whats coming up on this podcast through February 2023
In Europe, the development of novel pet food and treats is a significant factor, driven by increasing pet ownership and the humanization of pets, leading to a demand for premium and health-focused options
hello, lovely friends I reported on access issues around employer insurance last year, sharing interviews with Kristi Turner, who lost her coverage on New Year's Eve while everyone else was celebrating, and Jennifer Sansabrino, a small business owner who genuinely wanted to cover her employees but did not have a single formulary available to her with GLP-1s for weight loss